Local News

• Howard Feldman joins Bristol-Myers Squibb as vice president and therapeutic area head  Bristol-Myers Squibb announced that Dr. Howard Feldman has joined the company's Research and Development organization as vice president and therapeutic area head, Global Clinical Research, Neuroscience.
  Bristol-Myers Squibb Company January 08, 2009  
• Liquidia, Abbott team up to target cancer  One of the biggest challenges of cancer treatment is delivering drugs in a way that kills the bad cells without doing too much damage to healthy cells. The CEO of Liquidia Technologies hopes that a deal announced between his company and Abbott Laboratories will help to address that problem.
  Triangle Business Journal January 07, 2009  Jeff Drew
• Positive step for drug from engineered goat  In a surprise move, it seems likely the first genetically engineered animal approved for commercial use won't be a fast-growing salmon, as was expected, but a goat that produces an anti-clotting drug in its milk.
  USATODAY January 07, 2009  Elizabeth Weise
• FDA issues a Complete Response Letter for Lilly's olanzapine LAI  Eli Lilly and Company announced that it received a complete response letter from the U.S. Food and Drug Administration (FDA) for olanzapine long-acting injection (LAI) for acute and maintenance treatment of schizophrenia in adults.
  Eli Lilly and Company January 07, 2009  
• Health care could nab $100B payday  The $775 billion economic stimulus plan being cobbled together by President-elect Barack Obama and congressional Democrats could pump more than $100 billion into the health care sector, modernizing its delivery system and providing care to those who lost their health insurance.
  Politico January 07, 2009  Chris Frates
• Monsanto takes major step toward launch of world's first drought-tolerant corn product  As farmers around the world search for innovative new technologies to help them produce more with fewer resources, Monsanto Company announced that it is a major step closer to delivering the world's first-ever drought-tolerant corn product to farmers.
  Monsanto Company January 07, 2009  
• Monsanto increases full-year ongoing EPS guidance after reporting 117% earnings for 1Q2009  Greater demand in Latin America for Monsanto Company's products propelled the company to record-setting net sales and net income results for its fiscal 2009 first quarter, which ended Nov. 30, 2008.
  Monsanto Company January 07, 2009  
• U.S. Patent Office accepts Pfizer’s reissue application on Lipitor enantiome patent  Pfizer announced that the U.S. Patent & Trademark Office has issued a "Notice of Allowance" accepting the company's application to correct the technical defect in the '995 enantiomer patent for atorvastatin calcium, the salt form of atorvastatin sold as Lipitor.
  Pfizer Inc. January 06, 2009  
• Johnson & Johnson extends tender offer for Mentor Corporation  Johnson & Johnson announced it has extended its previously announced cash tender offer, through its wholly owned subsidiary, Maple Merger Sub, for all outstanding shares of common stock of Mentor Corporation until 5:00 p.m. (Eastern time), on January 16, 2009, unless further extended.
  Johnson & Johnson January 06, 2009  
• Monsanto announces yield gains with Deltapine Class Of 09  Monsanto Company announced its D&PL business will market five new varieties as the Deltapine Class of 09 for the coming production season. These varieties were introduced during the 2009 Beltwide Cotton Conferences that have brought the cotton industry together in San Antonio.
  Monsanto Company January 06, 2009  

   (next 10 articles)